Suppliers and packagers for TYLENOL

TYLENOL

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Kenvue Brands	TYLENOL	acetaminophen	TABLET, EXTENDED RELEASE;ORAL	019872	NDA	Kenvue Brands LLC	50580-309-01	1 BOTTLE in 1 CARTON (50580-309-01) / 24 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE	2016-01-18
Kenvue Brands	TYLENOL	acetaminophen	TABLET, EXTENDED RELEASE;ORAL	019872	NDA	Kenvue Brands LLC	50580-309-02	1 BOTTLE in 1 CARTON (50580-309-02) / 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE	2016-01-18
Kenvue Brands	TYLENOL	acetaminophen	TABLET, EXTENDED RELEASE;ORAL	019872	NDA	Kenvue Brands LLC	50580-783-10	1 BOTTLE, PLASTIC in 1 CARTON (50580-783-10) / 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC	2015-07-13

Tylenol (Acetaminophen) Supply Chain Analysis

Last updated: February 19, 2026

Tylenol, the brand name for acetaminophen, relies on a multi-stage supply chain involving active pharmaceutical ingredient (API) manufacturers, excipient suppliers, and final product formulators. China and India are dominant sources for acetaminophen API.

Who are the Primary Suppliers of Acetaminophen API?

The global supply of acetaminophen active pharmaceutical ingredient (API) is concentrated among a limited number of manufacturers. The principal producers are located in China and India, with some capacity also present in Europe and North America.

• China: Historically, Chinese manufacturers have been the largest suppliers. Key entities include Hubei Biocause Pharmaceutical Co. Ltd. and Jiangsu Jiushou Pharmaceutical Co. Ltd. These companies operate large-scale production facilities and are significant contributors to the global acetaminophen supply.
• India: Indian pharmaceutical companies are also major players. Neuland Laboratories Ltd. and Granules India Ltd. are prominent suppliers of acetaminophen API. India's strength lies in its established chemical manufacturing infrastructure and cost-competitiveness.
• Europe and North America: While less dominant than Asian suppliers, some production capacity exists. Companies like Aceto Corporation (which has API manufacturing capabilities through acquisitions) and smaller, specialized European manufacturers contribute to regional supply chains and offer diversification options.

The market is characterized by significant production volumes to meet global demand. Price, regulatory compliance, and reliability are key differentiators among these suppliers. The average price for acetaminophen API can fluctuate but has historically ranged from approximately $4 to $8 per kilogram, depending on volume, purity, and market conditions [1].

What are the Key Excipients Used in Tylenol Formulations?

Beyond the active ingredient, acetaminophen tablets and other formulations utilize various excipients that are crucial for tablet formation, stability, and drug delivery. These include binders, fillers, disintegrants, and lubricants.

• Fillers/Diluents: These add bulk to the tablet.
  • Microcrystalline Cellulose (MCC): A common binder and filler providing tablet hardness.
  • Lactose Monohydrate: Another widely used filler, although its use is declining in favor of lactose-free alternatives due to patient allergies.
  • Starch (Corn Starch, Potato Starch): Used as both a filler and a disintegrant.
• Binders: These hold the ingredients together to form granules.
  • Povidone (Polyvinylpyrrolidone, PVP): A synthetic binder effective in wet granulation processes.
  • Hydroxypropyl Methylcellulose (HPMC): Often used for its binding and film-forming properties.
• Disintegrants: These help the tablet break apart in the digestive tract.
  • Croscarmellose Sodium: A superdisintegrant that swells rapidly when exposed to water.
  • Sodium Starch Glycolate: Another effective disintegrant.
• Lubricants: These prevent sticking to tablet press machinery.
  • Magnesium Stearate: The most common lubricant in pharmaceutical tablet manufacturing.
  • Stearic Acid: Also used as a lubricant.
• Glidants: Improve powder flow.
  • Colloidal Silicon Dioxide (Aerosil): Enhances powder flowability.

Major suppliers of pharmaceutical-grade excipients are global companies with specialized manufacturing capabilities. Companies like JRS Pharma, Roquette, Ashland, and BASF are significant providers of these essential components, adhering to stringent pharmaceutical quality standards (e.g., USP/NF, Ph. Eur.).

What are the Regulatory Requirements for Pharmaceutical Supply Chains?

The pharmaceutical supply chain for Tylenol is governed by strict regulatory frameworks to ensure product safety, efficacy, and quality. These regulations apply to both API and excipient manufacturers, as well as the final product formulators.

• Good Manufacturing Practices (GMP): Mandated by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). GMP ensures that products are consistently produced and controlled according to quality standards. Manufacturers must maintain detailed records of raw material sourcing, production processes, quality control testing, and distribution [2].
• Drug Master Files (DMFs): API manufacturers submit DMFs to regulatory agencies. A DMF is a submission to the FDA that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drugs. This allows regulators to review the API without disclosing proprietary information to the drug product manufacturer [3].
• ICH Guidelines: The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) provides harmonized guidelines on quality, safety, efficacy, and multidisciplinary topics. Key ICH guidelines relevant to the supply chain include Q7 (GMP for APIs) and Q11 (Development and Manufacture of Drug Substances) [4].
• Supplier Audits and Qualification: Pharmaceutical companies conduct rigorous audits of their suppliers to ensure compliance with GMP and other regulatory requirements. Supplier qualification processes involve assessing a supplier's quality management system, manufacturing capabilities, and regulatory history.

Adherence to these regulations is non-negotiable for suppliers participating in the Tylenol supply chain. Non-compliance can lead to product recalls, import alerts, and severe financial penalties.

How Does Supply Chain Robustness Impact Tylenol Availability?

The robustness of the Tylenol supply chain is critical for ensuring consistent product availability to consumers. Disruptions can arise from various factors.

• Geopolitical Factors: Trade disputes, tariffs, and political instability in key manufacturing regions can disrupt the flow of raw materials and finished APIs. For example, reliance on a single geographic region for API production creates vulnerability.
• Natural Disasters and Pandemics: Events like earthquakes, floods, or global health crises (e.g., COVID-19) can halt production, disrupt transportation networks, and strain raw material availability. The pandemic highlighted the fragility of global supply chains, leading to shortages of various pharmaceutical ingredients.
• Environmental Regulations: Stricter environmental regulations in API manufacturing hubs, particularly in China, have led to plant closures or increased operating costs due to compliance requirements. This can reduce overall supply and increase prices.
• Quality Control Issues: Unexpected quality failures or recalls from a major API supplier can immediately impact the availability of downstream drug products. Regular testing and robust quality management systems at all levels are essential to mitigate this risk.
• Logistics and Transportation: The efficient movement of raw materials and finished goods is vital. Bottlenecks in shipping, port congestion, or increased freight costs can delay deliveries and affect product availability.

To enhance robustness, pharmaceutical companies often implement strategies such as:

• Dual Sourcing: Qualifying multiple suppliers for critical APIs and excipients across different geographic regions.
• Inventory Management: Maintaining adequate safety stocks of raw materials and finished products.
• Supply Chain Visibility: Utilizing technology to track materials and identify potential disruptions in real-time.
• Long-Term Contracts: Securing stable supply agreements with key vendors.

What is the Market Landscape for Acetaminophen API Manufacturers?

The market for acetaminophen API is highly competitive and influenced by global demand, raw material costs, and manufacturing efficiencies.

• Market Size: The global acetaminophen market, encompassing both API and finished product, is valued in the billions of dollars. The API segment is a significant portion of this, driven by widespread use in over-the-counter (OTC) and prescription medications.
• Key Players: As noted, Hubei Biocause Pharmaceutical and Jiangsu Jiushou Pharmaceutical are among the largest global producers, collectively accounting for a substantial share of the world's acetaminophen API output [5]. Granules India is another major player, with significant API production capacity.
• Competitive Dynamics: Competition is driven by price, quality (purity, impurity profiles), reliability of supply, and regulatory compliance. Manufacturers strive for economies of scale to reduce production costs.
• Consolidation and Expansion: The market has seen periods of consolidation and strategic expansion. Companies may acquire smaller competitors or invest in new production lines to increase capacity and market share.
• Impact of Generic Competition: The widespread availability of generic acetaminophen products intensifies price competition among API manufacturers. Manufacturers must be highly efficient to remain competitive.

The supply dynamics are closely watched by major pharmaceutical brands like McNeil Consumer Healthcare (a subsidiary of Johnson & Johnson, the owner of the Tylenol brand), who manage their supply chains to ensure a steady flow of high-quality API.

What are the Future Trends in Acetaminophen Supply Chains?

Several trends are shaping the future of acetaminophen supply chains.

• Increased Regionalization: Following the vulnerabilities exposed by recent global events, there is a growing emphasis on diversifying supply chains and reducing over-reliance on specific geographic regions. This may lead to increased API manufacturing capacity in North America and Europe, though cost remains a significant barrier.
• Technological Advancements: Innovations in chemical synthesis, continuous manufacturing, and advanced process control are being explored to improve efficiency, reduce waste, and enhance the quality of API production.
• Sustainability Initiatives: Growing pressure for environmentally sustainable manufacturing practices may influence supplier selection and drive investment in greener chemical processes and waste reduction technologies.
• Enhanced Traceability and Transparency: The demand for greater supply chain transparency, enabled by technologies like blockchain, is increasing. This allows for better tracking of materials from source to finished product, improving traceability and accountability.
• Supply Chain Resilience Planning: Companies are investing more in sophisticated risk assessment and resilience planning to anticipate and mitigate potential disruptions, including scenario planning for geopolitical events, natural disasters, and public health emergencies.

These trends suggest a move towards more diversified, resilient, and technologically advanced supply chains for critical pharmaceutical ingredients like acetaminophen.

Key Takeaways

• Acetaminophen API production is dominated by manufacturers in China and India, with Hubei Biocause and Jiangsu Jiushou being major suppliers.
• Excipients like microcrystalline cellulose, lactose, starch, povidone, and magnesium stearate are crucial and sourced from specialized global suppliers.
• Strict regulatory compliance, including GMP and DMF submissions, is paramount for all supply chain participants.
• Supply chain robustness is challenged by geopolitical factors, natural disasters, environmental regulations, and quality control issues.
• The acetaminophen API market is competitive, driven by price, quality, and reliability, with potential for increased regionalization and technological adoption in the future.

Frequently Asked Questions

1. Are there any significant API suppliers for acetaminophen in the United States? While the majority of large-scale acetaminophen API production is concentrated in Asia, some North American companies do produce or distribute pharmaceutical ingredients, although their market share for acetaminophen API is considerably smaller than that of Chinese and Indian manufacturers. Aceto Corporation has had API manufacturing capabilities [6].

2. What is the typical lead time for ordering acetaminophen API from overseas suppliers? Lead times can vary significantly but typically range from 2 to 4 months for large orders of acetaminophen API from Asian suppliers, accounting for production schedules, quality testing, and international shipping. This can be extended by customs delays or transportation issues.

3. How do pharmaceutical companies ensure the quality of acetaminophen API sourced from different suppliers? Companies employ a multi-faceted approach including rigorous supplier qualification processes, on-site audits to verify GMP compliance, detailed analytical testing of incoming raw materials (API) for purity and impurity profiles, and ongoing performance monitoring. They also review supplier's Drug Master Files (DMFs) submitted to regulatory agencies.

4. What are the primary risks associated with relying heavily on a single supplier for acetaminophen API? Key risks include supply disruption due to the single supplier's production issues (e.g., plant maintenance, quality failures, or regulatory action), price escalation due to lack of competitive pressure, and vulnerability to geopolitical or natural disaster events impacting that specific supplier's region.

5. How have recent global supply chain disruptions (e.g., COVID-19 pandemic) impacted the availability and cost of acetaminophen? The pandemic exposed vulnerabilities, leading to temporary shortages and increased costs for many pharmaceutical ingredients, including acetaminophen API. Disruptions in manufacturing, logistics, and increased demand for essential medicines contributed to these challenges, prompting many companies to re-evaluate their supply chain strategies for greater resilience.

---

Citations

[1] Grand View Research. (2023). Acetaminophen Market Size, Share & Trends Analysis Report by Application, by Region, and Segment Forecasts, 2023 - 2030. Retrieved from https://www.grandviewresearch.com/industry-analysis/acetaminophen-market (Note: Specific price ranges are indicative and subject to market fluctuations; this source provides market overview.)

[2] U.S. Food and Drug Administration. (n.d.). Current Good Manufacturing Practice (CGMP) Regulations. Retrieved from https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practice-cgmp-regulations

[3] U.S. Food and Drug Administration. (2018). Drug Master Files (DMFs). Retrieved from https://www.fda.gov/drugs/investigational-new-drug-applications-ind/drug-master-files-dmfs

[4] International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (n.d.). ICH Guidelines. Retrieved from https://www.ich.org/products/guidelines (Specific guidelines like ICH Q7 and Q11 are referenced in industry practice.)

[5] Various industry reports and financial disclosures from companies like Hubei Biocause Pharmaceutical Co. Ltd. and Jiangsu Jiushou Pharmaceutical Co. Ltd. (Note: Specific market share percentages are proprietary and fluctuate; general industry understanding is based on reported production capacities and market presence.)

[6] Aceto Corporation. (n.d.). Active Pharmaceutical Ingredients. Retrieved from https://www.aceto.com/pharma/active-pharmaceutical-ingredients/ (Note: While Aceto is a supplier of pharmaceutical ingredients, their specific role in acetaminophen API manufacturing may evolve.)